tiprankstipranks
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market

Halozyme (HALO) Technical Analysis

Compare
982 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
1Neutral
7Bearish
Technical Analysis Consensus
Strong Sell
2Bullish
1Neutral
7Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is 1.94, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 61.84, while Halozyme Therapeutics’s (HALO) share price is $64.84, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 58.77, while Halozyme Therapeutics’s (HALO) share price is $64.84, making it a Buy.

Halozyme (HALO) Pivot Points

Mar 26, 2025, 09:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
59.43
61.14
62.58
64.29
65.73
67.44
68.88
Fibonacci
61.14
62.34
63.09
64.29
65.49
66.24
67.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Mar 26, 2025, 09:26 PM
Period
Simple
Exponential
MA5
64.53Buy
64.26Buy
MA10
63.24Buy
63.36Buy
MA20
61.34Buy
61.84Buy
MA50
58.51Buy
58.77Buy
MA100
54.44Buy
56.28Buy
MA200
54.98Buy
53.95Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 63.36, while Halozyme Therapeutics’s (HALO) share price is $64.84, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 56.28, while Halozyme Therapeutics’s (HALO) share price is $64.84, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $64.84 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 58.51, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $64.84 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 54.44, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $64.84 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 54.98, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Mar 26, 2025, 09:26 PM
Name
Value
Implied Action
RSI (14)
71.99
Sell
STOCH (9,6)
80.96
Sell
STOCHRSI (14)
85.64
Sell
MACD (12,26)
1.94
Sell
ADX (14)
57.52
Sell
Williams %R
-16.98
Sell
CCI (14)
111.12
Sell
ATR (14)
1.75
-
Ultimate Oscillator
64.53
Neutral
ROC
8.92
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 71.99, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 57.52, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is 111.12, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 8.92, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Buy.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 71.99, which suggests HALO is a Sell.
      What is HALO’s MACD?
      HALO’s MACD is 1.94, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 64.53, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 61.34, which suggests HALO is a Buy.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 58.51, which suggests HALO is a Buy.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 54.98, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -16.98, which suggests HALO is a Sell.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is 111.12, which suggests HALO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis